4-aminopyridine has been researched along with Chronic Inflammatory Demyelinating Polyradiculoneuropathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leussink, VI | 1 |
| Stettner, M | 1 |
| Warnke, C | 1 |
| Hartung, HP | 1 |
1 other study available for 4-aminopyridine and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
| Article | Year |
|---|---|
Fampridine-PR (prolonged released 4-aminopyridine) is not effective in patients with inflammatory demyelination of the peripheral nervous system.
Topics: 4-Aminopyridine; Disability Evaluation; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Po | 2016 |